Doximity Research and Development Expenses 2020-2025 | DOCS

Doximity research and development expenses for the twelve months ending June 30, 2025 were $0.097B, a 17.71% increase year-over-year.

  • Doximity annual research and development expenses for 2025 were $0.093B, a 13.48% increase from 2024.
  • Doximity annual research and development expenses for 2024 were $0.082B, a 2.24% increase from 2023.
  • Doximity annual research and development expenses for 2023 were $0.08B, a 28.61% increase from 2022.

Doximity Research and Development Expenses 2020-2025 | DOCS

  • Doximity annual research and development expenses for 2025 were $0.093B, a 13.48% increase from 2024.
  • Doximity annual research and development expenses for 2024 were $0.082B, a 2.24% increase from 2023.
  • Doximity annual research and development expenses for 2023 were $0.08B, a 28.61% increase from 2022.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$47.5B
Tempus AI (TEM)$14B
Hims & Hers Health (HIMS)$10.1B
IRhythm Technologies (IRTC)$5.4B
Hinge Health (HNGE)$4.5B
Inspire Medical Systems (INSP)$2.8B
Privia Health (PRVA)$2.7B
Heartflow (HTFL)$2.4B
Enovis (ENOV)$1.8B
10x Genomics (TXG)$1.8B
Phreesia (PHR)$1.8B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.5B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.4B
Claritev (CTEV)$1.2B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$666M
Zepp Health (ZEPP)$580M
Veradigm (MDRX)$525M
Standard BioTools (LAB)$485M
Talkspace (TALK)$469M
Butterfly Network (BFLY)$383M
Carlsmed (CARL)$346M
TruBridge (TBRG)$307M
Outset Medical (OM)$252M
SOPHiA GENETICS SA (SOPH)$244M
Health Catalyst (HCAT)$231M
Nyxoah SA (NYXH)$219M
KORU Medical Systems (KRMD)$203M